EXOZ
EXOZ
NASDAQ · Biotechnology

Exozymes Inc

$10.51
-0.34 (-3.13%)
As of Feb 8, 2:13 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 13.14M 13.93M 11.00M
Net Income -2,417,675 -2,785,079 -2,350,186
EPS
Profit Margin -18.4% -20.0% -21.4%
Rev Growth -4.0% +11.1% -5.6%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 20.75M 17.80M 17.56M
Total Equity 48.48M 47.03M 51.63M
D/E Ratio 0.43 0.38 0.34
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -3,490,436 -4,206,535 -3,083,781
Free Cash Flow -1,263,655 -1,934,401 -1,577,892